Publications:  Dr Stephane Bourgeois

Katsareli EA, Amerikanou C, Rouskas K, Dimopoulos A, Diamantis T, Alexandrou A, Griniatsos J, Bourgeois S et al.(2020). A Genetic Risk Score for the Estimation of Weight Loss After Bariatric Surgery. Obesity Surgery vol. 30, (4) 1482-1490.

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ et al.(2019). Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. Clinical Pharmacology and Therapeutics vol. 105, (6) 1477-1491.

Gottlieb A, Daneshjou R, DeGorter M, Bourgeois S, Svensson PJ, Wadelius M, Deloukas P, Montgomery SB et al.(2017). Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans. Genome Medicine vol. 9, (1)

Zhang JE, Klein K, Jorgensen AL, Francis B, Alfirevic A, Bourgeois S, Deloukas P, Zanger UM et al.(2017). Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response. Front Pharmacol vol. 8, 323-323.

Carr DF, Bourgeois S, Chaponda M, Takeshita LY, Morris AP, Castro EMC, Alfirevic A, Jones AR et al.(2017). Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. Journal of Antimicrobial Chemotherapy

De T, Nwanze N, Hernandez W, Smithberger E, Tuck M, O'Brien T, Kittles R, Duarte J et al. (2016). GENOME-WIDE ASSOCIATION STUDY TO IDENTIFY THE GENETIC DETERMINANTS OF WARFARIN INDUCED HEMORRHAGIC COMPLICATIONS IN AFRICAN AMERICANS (AAS). CLINICAL PHARMACOLOGY & THERAPEUTICS. vol. 99, S13-S13.

Bourgeois S, Jorgensen A, Zhang EJ, Hanson A, Gillman MS, Bumpstead S, Toh CH, Williamson P et al.(2016). A multi-factorial analysis of response to warfarin in a UK prospective cohort. Genome Medicine vol. 8, (1)

Parra EJ, Botton MR, Perini JA, Krithika S, Bourgeois S, Johnson TA, Tsunoda T, Pirmohamed M et al.(2015). Genome-wide association study of warfarin maintenance dose in a Brazilian sample. Pharmacogenomics vol. 16, (11) 1253-1263.

Nwanze N, Hernandez W, Tuck M, O'Brien T, Kittles R, Duarte J, Bourgeois S, Cavallari L et al. (2015). GENOME-WIDE ASSOCIATION STUDY TO IDENTIFY SUSCEPTIBILITY LOCI ASSOCIATED WITH HEMORRHAGIC COMPLICATIONS AMONG AFRICAN AMERICAN PATIENTS ON STABLE WARFARIN DOSE. CLINICAL PHARMACOLOGY & THERAPEUTICS. vol. 97, S66-S66.

Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC et al.(2013). Genetic variants associated with warfarin dose in African-American individuals: A genome-wide association study. The Lancet vol. 382, (9894) 790-796.

Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S et al.(2012). miR-133a regulates Vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the Vitamin K cycle. Molecular Medicine vol. 18, (11) 1466-1472.

McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavi¿iute D, Carrington M, Sills GJ, Marson T et al.(2011). HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine vol. 364, (12) 1134-1143.

Yotova V, Lefebvre J-F, Moreau C, Gbeha E, Hovhannesyan K, Bourgeois S, Bedarida S, Azevedo L et al.(2011). An X-Linked Haplotype of Neandertal Origin Is Present Among All Non-African Populations. Molecular Biology and Evolution vol. 28, (7) 1957-1962.

Alfirevic A, Bourgeois S, Jorgensen A, Steen K, Weetman D, Park BK, Deloukas P, Pirmohamed M (2010). Carbamazepine-induced hypersensitivity in Caucasians and genetic variability in the major histocompatibility complex. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. vol. 70, 298-298.

Bourgeois S, Yotova V, Wang S, Bourtoumieu S, Moreau C, Michalski R, Moisan J-P, Hill K et al.(2009). X-chromosome lineages and the settlement of the Americas. American Journal of Physical Anthropology vol. 140, (3) 417-428.

Takeuchi F, McGinnis R, Bourgeois S, Barnes C, Eriksson N, Soranzo N, Whittaker P, Ranganath V et al.(2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genetics vol. 5, (3)

Bedoya G, Montoya P, Garcia J, Soto I, Bourgeois S, Carvajal L, Labuda D, Alvarez V et al.(2006). Admixture dynamics in Hispanics: A shift in the nuclear genetic ancestry of a South American population isolate. Proceedings of the National Academy of Sciences vol. 103, (19) 7234-7239.

Lovell A, Moreau C, Yotova V, Xiao F, Bourgeois S, Gehl D, Bertranpetit J, Schurr E et al.(2005). Ethiopia: between Sub-Saharan Africa and Western Eurasia. Annals of Human Genetics vol. 69, (3) 275-287.

Yotova V, Labuda D, Zietkiewicz E, Gehl D, Lovell A, Lefebvre J-F, Bourgeois S, Lemieux-Blanchard É et al.(2005). Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec. Human Genetics vol. 117, (2-3) 177-187.

LABUDA D, Krajinovic M, BOURGEOIS S(2005). Allele specific oligonucleotide hybridization (ASO). Encyclopaedia of Diagnostic Genomics and Proteomics, volume 2., CRC PressI Llc

Bourgeois S, Labuda D(2004). Dynamic allele-specific oligonucleotide hybridization on solid support. Analytical Biochemistry vol. 324, (2) 309-311.

Xiao F-X, Yotova V, Zietkiewicz E, Lovell A, Gehl D, Bourgeois S, Moreau C, Spanaki C et al.(2003). Human X-chromosomal lineages in Europe reveal Middle Eastern and Asiatic contacts. European Journal of Human Genetics vol. 12, (4) 301-311.